Clinical Trials Browser

Not yet recruiting × Lymphoma × selinexor × Clear all

NCT06573151 2024-08-27

Selinexor, Anti-PD-1 Antibody and P-GemOx Regimen in R/R NKTCL

Phase 2 Not yet recruiting

Lymphoma